AceLink Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch AceLink Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers (NCT04908462) | AceLink Therapeutics, Inc. | 2021-06-08 |
Track AceLink Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.